The likely win here is premium compounding, not another explosive
rerating. Constellation should improve revenue quality as more output moves into long-duration, reliability-sensitive contracts and as
Calpine broadens its shaped power offering. That supports higher cash generation and some balance-sheet improvement, but regulatory gates and an already expensive starting point keep the most likely outcome below true hypergrowth.